New analysis confirms canagliflozin’s cardiovascular and kidney benefits in older adults

Sodium-glucose co-transporter 2 (SGLT2) inhibitors reduce the risk of cardiovascular and kidney outcomes in patients with type 2 diabetes, but it is unclear whether their effects differ based on patients’ age.

Best Buy to sell continuous glucose monitoring systems

Dive Brief: Best Buy plans to start selling continuous glucose monitors in the next few weeks, in the tech retailer’s first foray into prescription-based medical device

October 9, 2023

CDEs: A New Frontline in Healthcare Cybersecurity

Tim Quinlan, Sr. Technical Manager at Coder It’s no surprise that one of healthcare leaders’ biggest fears is having customer data stolen, leaked or exposed.

September 27, 2024

Study suggests maternal adverse childhood experiences may become biologically embedded

Researchers investigated the transfer of biological embedding of life experience across generations by evaluating traumatic childhood experiences of mothers and epigenetic clocks in pregnant mothers

August 13, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.